Recommended
More Related Content
Similar to Sudhir4singh@gmail.com
Similar to Sudhir4singh@gmail.com (20)
Recently uploaded
Recently uploaded (20)
Sudhir4singh@gmail.com
- 2. 1 Funnel
- 3. 2 Two Quadrant Easy 2 step registration Competitive prices
- 5. 4 Two Quadrant TEXT TEXT TEXT • TEXT TEXT • TEXT
- 6. 5 Two Quadrant Text Text ■ Text ■ Text Text Text
- 7. 6 Two Quadrant • TEXT Project Background • TEXT Project Objectives
- 8. 7 Two Quadrant • TEXT Jobs’ Profile • TEXT
- 9. 8 Two Quadrant • Text • Text OutcomePurpose
- 10. 9 Two Quadrant • Text • Text Marketing on Sales Sales on Marketing
- 11. 10 Two Quadrant • Text• Text
- 14. 13 Three Quadrant Quality & usability Value Service
- 15. 14 Three Element VALUE Increasing Market Complexity Demonstrating Value of Medicines Doing More With Less • Text • Text • Text
- 16. 15 Three Quadrant LEADING SOURCE GLOBALLY SCALED IT INFRASTRUCTURE GLOBAL TEAM OF EXPERTS
- 17. 16 Three Quadrant 29 36 35 ASA ASA AS % % %
- 18. 17 Three Quadrant • TEXT • TEXT • TEXT
- 19. 18 Three Quadrant Improve Value • TEXT • TEXT Increase Operational Efficiency Better Manage Regulatory/ Legal Issues • TEXT
- 20. 19 Three Quadrant TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT
- 21. 20 Three Quadrant Heading • Text TEXT Heading • Text TEXT Heading • Text TEXT Option 1 Option 2 Option 3
- 22. 21 Three Quadrant Text Text Text • Text • Text • Text
- 23. 22 Three Quadrant Text Text Text Text Text • Text
- 24. 23 Three Quadrant Text 1. Text Text 1. Text Text 1. Text Development
- 25. 24 Three Quadrant Text Text Text • Text • Text • Text
- 26. 25 Three Quadrant Text • Text Text • Text Text • Text TEXT TEXT TEXT TEXT
- 27. 26 Three Bullet Text TextText • Text • Text • Text Text
- 28. 27 Three Quadrant Number of territories Number of ineligible Number of vacant territories
- 29. 28 Three Quadrant • Text • Text • Text Text Text Text
- 31. 30 Three Quadrant Text Text • Text • Text • Text Text Text Text
- 32. 31 Three Quadrant Heading • Text Heading • Text Heading • Text
- 33. 32 Four Quadrant Heading • Text Heading • Text Heading • Text Heading • Text
- 34. 33 Four Quadrant • Text • Text • Text• Text Text
- 35. 34 Four Bullet • Text • Text • Text • Text Text Text Text Text
- 36. 35 Four Quadrant Text • Text • Text• Text • Text
- 37. 36 Four Quadrant • Text • Text • Text • Text
- 41. 40 Four Quadrant Text 1. Text Text 1. Text Text 1. Text Text 1. Text Text
- 43. 42 Four Quadrant Text Treatment • Text Treatment Text Treatment • Text Treatment Text Treatment • Text Treatment Text Treatment • Text Treatment
- 44. 43 Four Quadrant Heading • Text Heading • Text Heading • Text Heading • Text Text
- 45. 44 Four Quadrant TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT
- 46. 45 Four Quadrant Offering Description • TextText • TextText • TextText • TextText
- 47. 46 Five Quadrant Who? … did it happen to? Category, segment, manufacturer, brand What? … happened? New development, changes in the trend Why? … did it happen? Regulations, promotions, price, distribution, consumer behaviour, weather, media, demographics etc Where? … did it happen? Country, region, channel, store type When? … did it happen? Weekly, monthly, quarterly, annually
- 51. 50 Six Quadrant The quick brown fox jumps over the lazy dog. The quick brown fox jumps over the lazy dog. The quick brown fox jumps over the lazy dog. The quick brown fox jumps over the lazy dog. The quick brown fox jumps over the lazy dog. The quick brown fox jumps over the lazy dog. Text
- 53. 52 Nine Element TextText TextText Text TextText TextText 260+ million unique patients and 2M+ providers
- 54. 53 Ten Quadrant Faster Access New Capabilities Preserve Intellectual Property Flexible Models Costs InnovationPortfolio Best Practices Standards Market Complexity
- 55. 54 Circle $
- 59. 58 Message “ ” A principle driven, tool based philosophy that focuses on eliminating waste so that all activities/steps add value from the customers perspective. LEAN Thinking is all about continuous waste elimination !
- 63. 62 Message • Text • Text • Text • Text • Text • Text
- 64. 63 Message Text
- 65. 64 Bullet Points 1 What 3 When 5 Where 6 Who 2 Why 4 How
- 66. 65 Images Market Assessment Social Media Analytics KOL Market Prognosis Integrated Desk Research Competitive Intelligence Forecasting Primary Market Research Disease Insights
- 67. 66 Infographic #1 #2 #3 #4 #5 #6 #7 #8 #9 Aliquam blandit ante eu lorem faucibus Cras tristique nibh fringilla cursus convallis Maecenas consequat nunc sed est suscipit Lorem Ipsum is simply dummy text
- 68. 67 Infographic Lorem IpsumTitle Lorem Ipsum issimplydummy text of theprinting andtypesettingindustry. Lorem Ipsum hasbeenthe industry'sstandarddummy text ever sincethe 1500s,whenan unknown printertook a galleyof typeandscrambledit to make a typespecimenbook. Integer sit amet ligula Nulla at arcu vitae quam rutrum facilisis. Aliquam blandit ante eu Sedvitae dolor nec est tempusmolestie. Aenean ultrices odioac Sedcongue lacus cursus, laoreetenimin, auctor augue. Integer ornare nibh Crastristique nibh fringilla cursus convallis. Contrary topopular belief Integerornarenibh vitae justo vehicula tincidunt. Nullam idmauris ornare Aliquam blandit anteeu lorem faucibus accumsan. Nulla sed velithendrerit Morbi pellentesquenisi et hendreritpretium. Nunc nec justovelfelis Maecenas consequat nunc sedestsuscipit lobortis.
- 69. 68 Infographic 00% 00% 00% Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s. Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage.
- 70. 69 Infographic Nunc nec justo vel felis mollis vestibulum a ac • Phasellus nec tellus ac leo ornare • Cras tristique nibh fringilla cursus convallis • Sed congue lacus cursus, laoreet enim in • Sed vitae dolor nec est tempus molestie • Etiam eu ipsum suscipit, tempus eros non • Mauris id eros et magna eleifend suscipit sit • Suspendisse rhoncus tellus non erat pharetra • Sed vitae dolor nec est tempus molestie • Phasellus at elit dignissim nulla ornare • Suspendisse vitae turpis mollis, sodales sapien • Curabitur quis odio semper, scelerisque • Sed congue lacus cursus, laoreet enim in • Nulla at arcu vitae quam rutrum facilisis • Vestibulum nec neque vehicula, pretium elit • Etiam eu ipsum suscipit, tempus eros • Suspendisse rhoncus tellus non erat pharetra • Cras tristique nibh fringilla cursus convallis • Vestibulum nec neque vehicula, pretium elit Nullam id mauris ornare, rhoncus orci at, sagittis Nulla sed velit hendrerit, lacinia lectus nec Integer ornare nibh vitae justo vehicula Aenean ultrices odio ac lectus iaculis, et Aliquam blandit ante eu lorem faucibus Nunc nec justo vel felis mollis vestibulum a ac
- 71. 70 Infographic JANUARY 2013 APRIL 2013 JULY 2013 OCTOBER 2013 Morbi pellentesque Cras tristique Integer sit amet Maecenas consequat Aenean ultrices Maecenas consequat nunc sed est suscipit lobortis Aliquam blandit Curabitur quis odio semper, scelerisque tellus non Curabitur quis Integer sit amet ligula egestas, laoreet sapien eu, malesuada turpis Maecenas consequat Nullam id mauris ornare, rhoncus orci at, sagittis tellus
- 72. 71 Infographic Nullam id mauris Curabitur quis odio semper Aliquam blandit Phasellus nec tellus ac leo Curabitur quis Cras tristique nibh fringilla Integer sit amet Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words. Maecenas consequat nunc Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source. Integer sit amet Nullam id mauris ornare Sed vitae dolor Aenean ultrices odio ac lectus Phasellus at elit Integer sit amet ligula egestas Morbi pellentesque looked up one of the more obscure Latin words, consectetur. Aliquam blandit The first line of Lorem Ipsum, “Lorem ipsum dolor sit amet...”
- 73. 72 Infographic Nullam id mauris ornare hasellus at elit dignissim nulla ornare lobortis vel vitae sem.` Integer ornare nibh Sed vitae dolor nec est tempus molestie. Curabitur quis odio Sed congue lacus cursus, laoreet enim in, auctor augue. Maecenas consequat Cras tristique nibh fringilla cursus convallis. The first line of Lorem Ipsum, "Lorem ipsum dolor sit amet..", comes from a line in section 1.10.32. This book is a treatise on the theory of ethics, very popular during the Renaissance. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old.
- 74. 73 Infographic Lorem IpsumTitle Nunc nec justo vel felis mollis vestibulum a ac purus Sed vitae dolor Integer ornare nibh vitae justo vehicula tincidunt Phasellus at elit Aenean ultrices odio ac lectus iaculis Cras tristique nibh Aliquam blandit ante eu lorem faucibus accumsan Nulla at arcu Curabitur quis odio semper, scelerisque tellus non Phasellus nec tellus Maecenas consequat nunc sed est suscipit Sed congue lacus Phasellus nec tellus ac leo ornare accumsan Suspendisse rhoncus Cras tristique nibh fringilla cursus
- 75. 74 Infographic Sed vitae dolor Aliquam blandit ante eu lorem faucibus Nulla at arcu vitae hasellus nec tellus ac leo ornare Etiam eu ipsum Suspendisse rhoncus tellus non erat Suspendisse rhoncus Nulla at arcu vitae quam rutrum facilisis Cras tristique nibh Etiam eu ipsum suscipit, tempus eros Mauris id eros et Mauris id eros et magna eleifend suscipit Phasellus at elit Suspendisse vitae turpis mollis, sodales Curabitur quis odio Vestibulum nec neque vehicula, pretium elit Sed congue lacus Sed congue lacus cursus, laoreet enim laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
- 77. 76 Infographic 20,000 Nullam id mauris ornare, rhoncus orci Nulla sed velit hendrerit, lacinia Aliquam blandit ante eu lorem 40,000 Integer sit amet ligula egestas laoreet Maecenas consequat nunc sed est suscipit Phasellus nec tellus ac leo ornare 60,000 Sed congue lacus cursus, laoreet enim Sed vitae dolor nec est tempus molestie Phasellus at elit dignissim nulla ornare 80,000 Integer ornare nibh vitae justo vehicula Aenean ultrices odio ac lectus iaculis Cras tristique nibh fringilla cursus 10,0000 Sed vitae dolor nec est tempus molestie Phasellus at elit dignissim nulla ornare Vestibulum nec neque vehicula, pretium elit
- 80. 79 Infographic Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text Text TextText Text Text Text Text
- 83. 82 Infographic Text Text Heading • Text Heading • Text Heading • Text Heading • Text Heading • Text Text
- 85. 84 Infographic
- 87. 86 Infographic *45% of all enrolled 20 19 9 12 9 • Enrolled – 20 at each Location • Attendance – 50% by session 3 • Assignment s – 80% • Test – 75% scored more than 75%
- 88. 87 InfographicInduction SoftSkills FunctionalSkill • HR Induction • Enabler Sessions • On boarding formalities • IMS Now and ARC Tour • Mantras • Personal Effectiveness and Business Etiquette • Business writing Skills • Introduction to Global English and SkillPort • Pharmaceutic al Industry • IMS Products and Services • PowerPoint Basics – IMS Templates • Delivery Excellence Standards and Templates
- 89. 88 Infographic Imparting Training: • 200 Training sessions per year • Monthly induction program • 3000-4000 training hours • Identify 30 trainers Getting Trained: • 150 Trainee hours for each new joiner • 500 Trainee hors per campus joiner
- 90. 89 Infographic Hiring Flu/Cold/Respiratory Activity Notification (FAN) OTC Review Global Senior Management Report Current Status Engagement Model Appendix I. II. III. IV.
- 91. 90 Infographic Global Senior Management Report Engagement Model Process Management
- 93. 92 Infographic Transition Framework Governance Plan Transition Best Practices Regular Transition Tracking and Reporting
- 94. 93 Infographic Transition Best Practices Regular Communication Transition Best Practices Quality Management Process Appendix
- 95. 94 Infographic 21% 11% 54% 6% 4% 4% USCES US Strategy & Pharma Solutions IMSCG Global Oncology Disease Insights India IMS Institute • Text • Text • Text • Text • Text • Text Text Text Text Text Text Text Lead Project Types
- 96. 95 Infographic TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT
- 99. 98 Infographic Managing Operations Making Strategic Decisions “Choosing the right road” “Running well on the chosen road”
- 100. 99 Infographic Commitment to Action Logically Correct Reasoning Appropriate Frame Elements of Decision Quality Meaningful, Reliable Information Clear Values and Trade-offs Creative, Doable Alternatives
- 101. 100 Infographic
- 102. 101 Infographics Social networking Customer Text messages Direct mail responses Medical apps and portal visits Website visits and registrations Email and survey responses Mobile apps Customer service call Telesales detail KOL/ Thought leader Sales rep detail with iPad Remote speaker education and programs Conventions Devices/ search engines Personal interactions Non-personal interactions
- 103. 102 Infographic Text
- 105. 104 Infographic
- 106. 105 Triangle
- 107. 106 Infographic Applications (consuming and generating data) Targeting and Segmentation Analytics Territory Alignment Campaign Management Compliance Systems Client data storeRaw data sources DxRxHCRSSales CRM IC IMS data offerings
- 108. 107 Infographic
- 109. 108 Infographic +
- 110. 109 Image
- 111. 110 Infographic
- 113. 112 Infographic
- 114. 113 Image
- 117. 116 Infographic TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXTTEXT
- 118. 117 Infographic Complaint Resolution Late Fee Waiver + Complaint Resolved 100% Success Purchase Authorised Acquisition With a 6 month interest free promo Payment Min. Balance received on due date Promo & Loyalty Offers Received 3 offers, Accepted 1
- 121. 120 Infographic 01 02 03 04 05 06 07 08 09 TEXT TEXT TEXT TEXT TEXT TEXT
- 122. 121 Infographic
- 123. 122 Infographic Corporate/ Brand strategy Investment/ Execution KPIs Stakeholder Impact KPIs Performance/ Market Results • TEXT • TEXT • TEXT • TEXT TEXT TEXT
- 124. 123 Infographic TEXT Interoperable technology Pre-integrated with industry data Global scale Flexibility to adapt TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT TEXT Interoperable technology Pre-integrated with industry data Global scale Flexibility to adapt
- 125. 124 Infographic Efficiencies in data management Aligned supporting systems & processes Speed in decision making and market interventions Improved comparability and transparency
- 126. 125 Infographic • TEXT• TEXT Strategy Support TEXT TEXT Increasing Productivity • TEXT• TEXT
- 128. 127 Infographic Expansion Potential Major Therapeutic Areas Auto Immune Metabolic CVS Neurodegenerative Gastro Intestinal Hematology Infectious Diseases Ophthalmology Clinical Leads 30 6 Development Candidates Orphan Diseases Suite Repurposingand Reformulation Suite Immuno-Oncology &Oncology Suite Opportunity: 9,000+ Orphan Diseases 250 Rare Disease set 2,000 APIs Opportunity: Reformulation & Repurposing Diseases CNS Diseases Combination Therapy Opportunity: 2,000 Assets & Multiple Modalities 30+ Tumors
- 130. 129 Infographic
- 131. 130 Infographic 11% Pharma 17% Life Sciences 17% Statistics & Economics 22% Programming 33% Marketing and Finance </> • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum
- 132. 131 • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum • Lorem Ipsum 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
- 133. 132 Infographic FULLY CUSTOMIZABLE ENGAGEMENT MODELS AS A SERVICEEPISODIC OUTSOURCING What We Do COMMERCIAL SERVICES RESEARCHANALYTICSOPERATIONS Building Next Generation Capabilities Driving Innovative Healthcare Analytics Integrating Primary and Secondary Insights
- 135. 134 Infographic Booming data availability Technology and virtualization revolution Globalization and capabilities Focus on innovation to drive growth and efficiencies
- 136. 135 Infographic What We Do Solutions Built For
- 138. 137 InfoGraphic People and Responsiveness Engagement and Communication Executive SponsorshipEducation
- 139. 138 Infographic • Text Historical Process IMS IT Market Research Sales Operation Brand Analysts Brand Managers Sales Rep
- 141. 140 Infographic
- 142. 141 Infographic ONSHORE-OFFSHORE PARTNERSHIP NEW OPPORTUNITIES IDENTIFICATION NEW PRODUCT LAUNCH • Aligned Objectives • New Product Development • New working model with “Fungible” resources • Analytics Link • New Disease Insight Reports • Enhanced Market Prognosis Coverage • New project types • New geographies • Increased adhoc engagements NEW CAPABILITY DEVELOPMENT • Oncology Center of Excellence • Forecasting Capabilities
- 143. 142 Logos 64+ diverse types of adhoc projects New Geographies for direct client projects ~10,000+ hrs from Delivery Center ~$1.5Mn worth of projects
- 144. 143 Infographic
- 145. 144 Infographic
- 147. 146 Five Element *Total team size = 105 Text Text Text Text Text Text
- 148. 147 Two Element It is: Text Our vision is: Text
- 149. 148 Infographic Evaluation Plan Decision Board Project Team Frame Alter- natives Issues Business Situation Market Assessment Influence Diagram • • • • • • • • Decision Hierarchy
- 150. 149 Infographic
- 151. 150 Infographic Test Well #1 Test Well #2 Test Well #3 *An upstream oil and gas veteran would call these “exploration wells,” not “test wells.”
- 152. 151 Infographic U-Shape Setup: Encourages participant dialogue Power position for leadership control Sideline position for reduced control with audience interaction Pace-changing position for defusing conflict or resuming control Conference Table Setup: For a smaller group Power position for leadership control
- 153. 152
- 154. 153 Point up? Point down?
- 155. 154 Six Element Appropriate Frame Creative, Doable Alternatives Meaningful, Reliable Information Clear Values and Trade- offs Logically Correct Reasoning Commitment to Action Elements of Decision Quality • Lack focus • Wrong scope • Wrong people • Wrong perspective • Not compelling • Born of delusion or pride • In the “comfort zone” • Too similar • Uncertainty ignored • Not “grounded” in reality • Difficult to trade off • Not defined • Not communicated • “Groupthink” • Too simplistic • “Analysis paralysis” • No alignment • Unable / unwilling to implement • “No action / no decision”
- 158. 157 Infographic
- 159. 158
- 160. 159 KOL Management Smart App KOL Identification KOL Database Refresh/ Maintenance KOL Network Analysis KOL Management Product KOL Social Media Analysis KOL Segmentation KOL Profiling KOL Engagement Planning
- 161. 160 Utilization Data Clinical Data Sensing Data User Generated Data Client Generated Data Channel Data IMS Health 2014 Client Conference
- 162. 161
- 163. 162 Success Areas • Strategic support and guidance from global ACE champions • Presence of Onshore Managers in US and EU regions • Strong processes adherence ensuring business continuity • Leveraging broader IMS capabilities Learnings • Synergies to create efficiencies & actionable insights: ‒ Across multiple work streams in ACE ‒ Hybrid project model to address out-of-scope activities • Presence of local champion & onshore representatives across regions • Better understanding of GE strategic process
- 164. 163 IMS P&MA Team: • 120+ specialists in Pricing and Market Access based in New York, California, UK /Europe, and Asia • 140+ highly qualified and multidisciplinary local specialists across EMEA • Employees come from varied backgrounds of pharmaceutical industry, science, medicine, economics, outcomes research, policy, market research, & consulting • Deep therapeutic knowledge • Teams are composed of scientific experts with backgrounds in clinical research, pharmacology, economics, health management, and health care research • 700+ scientific publications & presentations over last 2 years • Our experience in the pricing and market access area is unparalleled • In 2012 we carried out over 200 P&MA projects globally, across the developed and emerging markets • We have advised on all four of the most successful launches in pharmaceutical industry history • We are the only firm with the competence to address P&R issues on a global basis in US, Europe and Japan/Asia Pacific regions
- 165. 164
- 166. 165
- 168. 167 IMS Syndicated Analytics Introduction Disease & Patient Forecasting EVIDENCE-BASED INSIGHTS Market & Patient Dynamics Company Partnering Drug Life Cycle Management
- 169. 168 Therapy Area Understanding, Epidemiology, Primary Research Domain Expertise Forecasting, Data Analytics, Statistical Analysis, Valuations/Basic Financial Analysis, MS Excel Analytics Secondary Research, Competitive Intelligence, Patent Research, Report Writing Research
- 170. 169 Process documentation We have prepared exhaustive Input and Output QC checklists for all regular monthly projects Updated all the SOP’s and also created documents for Business Continuity planning (BCP) Knowledge sharing At our offshore delivery center we pay a lot of emphasis on knowledge sharing and have taken initiatives like trainings, session etc. Automation Team has worked on automation and have automated all the manual steps which has resulted in reduction in Turn around time by around ~60% Knowledge sharing
- 171. 170 Review overview of IMS/Medivo patient data relationship Consider patient journey and sources of measurement at each step Determine next steps
- 172. 171 Geographic • US Census region for all patients, State for a subset, zip-3 for a subset P+ Health Plan Claims Database Patient & Payer Mix • Commercial, Self-Insured Employers, Managed Medicare & Medicaid plans. PharMetrics Plus is the only health plan claims database that can explicitly identify Medicare Advantage patients Cost of Care Variables • Allowed, Paid and out of pocket patient liability information Patient Linking • Patients can be linked to other IMS claims data assets using a deterministic linking methodology Provider IDs • Providers can be identified in most recent years, through NPI (~50% of claims)
- 173. 172 Data Delivery (SE1.KPI1 & KPI2 ) Data Quality (SE2.KPI1 & KPI2) Query Resolution (SE3.KPI1 to KPI3) SSR Processing (SE4.KPI1 & KPI2) Data Delivery Monthly Data Delivery Weekly Change to published data – WHS Change to published data – HPA Change to published data – PBS Query Response Rate Query Resolution – Client Service Query Resolution – Other SSR Response rate SSR Execution Client satisfaction with service team Overall client satisfaction Q3 ‘14 84% 53% 0% -0.06% 0% 100% 100% 100% 2 1 Q4 ‘14 73% 0% 0% -0.06% 0% 100% 100% 100% 4 2 Customer Satisfaction (SE5.KPI1 & KPI2) KPI TitleCSF/Service Element (KPI#)
- 174. 173 CSF/Service Elementx KPI# KPI Title 2014 Q3 2014 Q4 Data Delivery SE1.KPI1 Data Delivery – Monthly 84% 73% SE1.KPI2 Data Delivery – Weekly 53% 0.00% Data Quality SE2.KPI1 Change to Published Data – Wholesaler 0.00% 0.00% SE2.KPI2 Change to Published Data – Hospital -0.06% -0.06% SE2.KPI3 Change to Published Data – PBS 0.00% 0.00% Query Resolution SE3.KPI1 Query response rate - - SE3.KPI2 Query resolution – Client Service 100% 100% SE3.KPI3 Query resolution – Other 100% 100% SSR Processing SE4.KPI1 SSR response rate - - SE4.KPI2 SSR execution 100% 100% Client Satisfaction SE5.KPI1 Client Satisfaction with service team 2 4 SE5.KPI2 Overall Client Satisfaction 1 2
- 175. 174 Overview of IMS Ambulatory EMR Linking P+ w/Ambulatory EMR & Other Sources IMS Ambulatory EMR Database Deep Dive Level Setting – What is “Linkable” Data Backup Slides
- 176. 175 • IMS Ambulatory EMR Database Description • Size & scope of IMS Ambulatory EMR database population • Key metrics & demographics of IMS Ambulatory EMR database
- 177. 176 Electronic Medical Records (EMR) Ambulatory: 23M patients from 40,000 physicians Oncology Electronic Medical Records (EMR) ~700,000 patients from 790 physicians Open source medical claims 150M patients from 80,000 providers Open source pharmacy claims 205M patients, 70% of all prescription claims in US Your clinical trial or registry data Laboratory results 40% of all outpatient lab tests in US Hospital charge master detail 8M inpatient encounters from >650 hospitals PharMetrics Plus Health plan claims 150M lives Mortality data 130M patients
- 180. 179 Forecasting
- 182. 181 Work Assignments Finanical Management Fixed charge Qaulity and Service $Service Driven • Services selected from standard catalogue (with set bundles/tiers for each service group) • Costs fixed for budget-year and pre- defined quality KPIs • Clear deliverables specified for both IMS and BMS IMS BMS
- 183. 182 Sales Effectiveness + Customer Insights Benchmark Investment Forecast Impact Perception Customer Engagements Holisticviewacrossareas andstakeholders HCP Patient Payer Provider Authorities
- 184. 183 Stakeholder Commitment • Organization ambition for Performance management Senior Leadership buy-in and sponsorship • Internal capabilities • In sourcing/outsourcing approach • budget to drive digital initiatives Change Management Practices • Existing Analytics Operating practices, investments • Adoption Principles, risks • Industrialization strategy – global/local/hybrid IT – Tools and Processes Maturity • Enterprise architecture strategy • Hosting and deployment models • Tools and standards, Level of reusability • Support and operation processes Commercial Analytics Practices • KPI Management Framework • Business Rules Management • Data Management models, Master Data Management • Usage, Distribution Performance Management Strategy Organization Strategy • Business Need and Expected Outcome • Critical Insight Factors • Organization Design • Current Maturity Level Assessment Analysis will show gaps in performance reporting in order to facilitate workshops to come up with innovative ways to fill these gaps. The project will provide guidance about standardizing reporting systems where applicable
- 185. 184 • Strategies setting the basis for critical success factors therefore selection of the right KPIs • Indicators on key input activities against stakeholders • Indicators on impact of engagement with stakeholders • Brand performance in patient acquisition and retention • Sales and market share growth Performance/ Market Results Stakeholder Impact KPIs Investment/ Execution KPIs Corporate/ Brand strategy Leading indicators Lagging indicators
- 186. 185 Develop a easy- to-use, desktop interface for the forecast model that can then be sent to the individual countries Forecast model will be prefilled with certain HQ level assumptions The model to be more intuitive in terms of the parameters to be updated from the countries and also to enter a variations in the forecast assumptions by the countries The model to have a version control for the countries and the HQ team to view the forecasts. Individual countries will have the access to only their forecasts using a password Streamline and standardize the forecast process
- 187. 186 Forecast Platform Application Areas Pre-launch planning1 Inline product forecasting2 Long range strategic & short range 3 Incidence & prevalence based 4 Oncology and general medicine market 5
- 189. 188 Forecasting Advanced Analytics Performance and BI SFE Technology Forecasting Team Analytics Team Performance Team SFE/IC Team Infrastructure Team Client IMS Onshore (Steering Committee) Client Partner (IMS Steering Committee) Client Help Desk AssignedServiceModel 9Dedicated,Shares,ServiceDesk) IMS Offshore Hub Forecasting CoE Analytics CoE Performance CoE SFE/IC CoE Operations Production Technology Flex Resources Shared Hub Lead IMS Support/QMS/Change Mgmt Infrastructure Support Knowledge Management InsightDesk Innovation Development
- 190. 189 First Name Surname Anne Marie Kacper Jeremy Sue Paul Matthew John Justin Richard Dave Brett Konstanczak Main Moore Skinnner Farr Geddes Sillince Lawrence Bull
- 191. 190 PROPOSAL AIM Give Roche confidence that IMS can deliver the required support and provide the building blocks to create the final contract Context and Introduction Outline why IMS is the ideal partner for Roche Capabilities and Case Studies Showcase what IMS will do to address Roche’s requirements Execution Model Explain how IMS will set up and run the RACE model Pricing Option Slide Roche RFP - CI and Analytics
- 192. 191 Context and Introduction • Outline why IMS is the ideal partner for Roche Capabilities and Case Studies • Showcase what IMS will do to address Roche’s requirements Execution Model • Explain how IMS will set up and run the RACE model Pricing 1 2 3 4 CONTENTS Give Roche confidence that IMS can deliver the required support and provide the building blocks to create the final contract PROPOSAL AIM
- 193. 192 PROPOSAL AIM Give Roche confidence that IMS can deliver the required support and provide the building blocks to create the final contract Context and Introduction Outline why IMS is the ideal partner for Roche Capabilities and Case Studies Showcase what IMS will do to address Roche’s requirements Execution Model Explain how IMS will set up and run the RACE model Pricing Roche RFP - CI and Analytics
- 194. 193
- 196. 195 Infographic Leading Source of real-world healthcare intelligence Global Team of Experts with deep knowledge of informatics, therapies and healthcare markets Globally Scaled IT infrastructure and broadest cloud-based application suites in healthcare
- 198. 197 Growth Symptoms or Awareness Research Self Care/ OTC&CPG Doctor/HCP Visit(s) Treatment • Online Use − Yahoo! − AdIQ (any website) − Multiple partners • Loyalty Card Data • Medical Claims • Hospital Activity • EMR/Health Plan Data • Prescription Use – Retail, Mail Order, Specialty, LTC • Procedures Consumer, Behavioral, and Attitudinal Metrics Available at Every Stage
- 199. 198 Power of Linked Data Power of Linked Data 198 Campaign Patient Trackand Measure CampaignHCP Trackand Measure RX Source of Business Treatment Naïve, New To Brand, Switch To, Switch From BRINTELLIX & competitive HCOS* HCP Patient
- 200. 199 Power of Linked Data Power of Linked Data 199 Campaign Patient Trackand Measure CampaignHCP RX Source of Business Treatment Naïve, New To Brand, Switch To, Switch From BRINTELLIX & competitive HCOS* HCP Patient Trackand Measure Option slide
- 201. 200 Power of Linked Data Power of Linked Data 200 HCP Patient RX Source of Business Treatment Naïve, New To Brand, Switch To, Switch From BRINTELLIX & competitive Patient HCPCampaign Campaign HCOS* Trackand Measure Trackand Measure Option slide
- 202. 201 Two Element IMS Solution • xxx Pfizer’s Requirement • xxx
- 203. 202 Infographic
- 205. 204 Three Element Key Stakeholders Physicians are still an important stakeholder group – Around 32% of the patients are getting a prescription from their physicians Maintaining the 1-to-1 engagement with the physicians remains to be impactful and most of the CH companies have dedicated SF lines With more than half the population gaining access to internet in the past few years in the GCC, social media can play a vital role in educating and attracting consumers MoH at KSA has provided information about diseases leading to chronic pain such as RA and osteoporosis More than70% of consumers in UAE seek medications at pharmacies by product name (without prescriptions) or ask for pharmacist’s recommendation Pharmacists in KSA are of the opinion that product detailing is highly influential in motivating them to recommend product to a consumer PHARMACIES
- 206. 205 Six Element One out of every 4 cranes on Earth is located in Dubai Dubai's artificial Palm Islands imported enough sand to fill 2.5 Empire State Buildings The Burj Al Arab uses enough gold inside to cover 46,265 Mona Lisa paintings The net worth of the four listed billionaires is roughly the GDP of Honduras The present rate of private car ownership in Dubai is as high as 541 cars for each 1000 person with an average number of passengers in each car as low as 1.3 people Forty percent of physical gold traded in 2013 occurred in Dubai. All together, it weighed more than 354 elephants Expected increase in Dubai population is 296% by the year 2020 and that will bring the expected number of private cars in Dubai is 1.5m car by the year 2020
- 207. 206 Two Element Size and growth of the pharmaceutical market What is the split between Retail vs. Government market?
- 210. 209
- 211. 210 Three Element • Continuous tracking of competitor developments • Pipeline assessment • Life cycle management • Brand performance • Customized portfolio analysis • BD&L opportunities • Product strategic positioning • Competitive landscape Competitive Intelligence Brand Specific Services Company Monitoring Services Market Studies • Market assessments • Scenario Analysis
- 212. 211 Provide an overview of why IMS Health UK is changing Launch the new Account Management and Client Service operating model Demonstrate the benefits to you and next steps
- 213. 212 Provide an overview of why IMS Health UK is changing Launch the new Account Management and Client Service operating model Demonstrate the benefits to you and next steps
- 214. 213 Expand our commercial capabilities Focus on functions and activities that can be done better, faster and more efficiently Leverage and share resources across all markets, globally Share and adopt best practices with greater speed Drive enterprise effectiveness with a flexible model that will provide optimal level of support by market Drive the agility necessary to help the Commercial organization react quickly to changes in market opportunities, strategies and business priorities
- 215. 214 Anonymized Patient-Level Information • IMS LifeLinkTM – the largest collection of scientifically validated, anonymized patient-level data assets • PharMetrics Plus • Hospital Charge Master • EMR: Ambulatory and Oncology • Laboratory test results • Pharmacy prescription (Rx) • Medical claims (Dx) • OTC claims Technology Enabled Analytics • Analytic tools that leverage powerful technologies to deliver scientific and commercial insights efficiently • RWE – IMS Evidence 360 Epidemiology & Observational Studies Scientific Communication & Medical Writing Pricing and Market Access (P&MA) Health Economics and Outcomes IMS’ Real-World Evidence Solutions
- 217. 216
- 218. 217
- 219. 218
- 220. 219 Three Element • Sales Reporting Application • Rx Reporting Application • SFE dashboard/Reporting • Prescription Radar • Web Crawler Application • Physician Survey Tool • MDM US Products • MDM Payer Plan • Quota Management System • KOL Application • Forecast Consolidator • Market Access Intelligence • Brand/Market Performance Dashboard Custom Solutions
- 221. 220 Management Defines strategic objectives and the role of IT in achieving these objectives Indicates how well the business needs are being fulfilled through the application Measures the level of satisfaction of the end user Evaluates the financial aspects against the portfolio Examines the Effectiveness of the organization in following best practices in software project management Analyses the Effectiveness of the portfolio from a Technology point-of-view Measures how effectively individual applications are being conceptualized implemented and operationally run
- 222. 221 Indicates how well the business needs are being fulfilled through the application Measures the level of satisfaction of the end user Evaluates the financial aspects against the portfolio Measures how effectively individual applications are being conceptualized implemented and operationally run Analyses the Effectiveness of the portfolio from a Technology point-of -view Examines the Effectiveness of the organization in following best practices in software project management Business owner Finance End User Process Technology Application owner Management Defines strategic objectives and the role of IT in achieving these objectives
- 223. 222 Stratified sample to focus on your key targets High ROI with quick, simple, broadly accessed solutions integrated via technology Meaningful cross country comparisons relevant to local tactical implementation Validated insights via benchmarking
- 224. 223 There are many panels with many unknowns ! You Pay Less and Get Much Better Insights! We use our Data to Find the Right Participants
- 225. 224 Flexible Service Model Adapt to increased BMS support needs over time Continuous support Strong and close relation with BMS analytic team Transparency No black box on tools and methodology. Consistency across geographies Best practices and shared all analytic methodology Non stop Innovations Latest analytics data & thinking on PM MCM Analytics acquisition Expertise & data knowledge Allow quick access to the analytic platform and support resources
- 226. 225 Architecture Aligned to maintain BMS ownership and flexibility to scale Platform Best of breed approach leveraging proven AWS/IMS technologies Accelerators Pre-built software, data models, API’s, library of business processes Efficiency Reduction in handoffs and complexity over time Delivery Model Designed to scale up and across geographies skill sets and languages Team Hands on experience in implementing BMS systems globally
- 227. 226 1 2 3 4 Focus and dedicated HQ penetration and selling Marketing and offering development Bench, Reach, Skills – Ability to Respond fast to client both in EU & US Operations, Processes & Platform – Service the needs in the market
- 228. 227 Message In late 2013, Bristol-Myers Squibb announced the creation of a single, fully integrated global commercial organization that would be able to better support our evolving specialty care product portfolio and pipeline. Its aim is to be consistently superior in executing our commercial strategy across each brand and geographical location. Changes were also announced to better align and focus the Global Finance, Strategic Planning, and Business Development groups, along with Enterprise Services and Global Manufacturing and Supply. These changes are creating a more focused company, concentrated on a smaller number of core assets and priorities. This focus will enable R&D and Medical Affairs to better partner and align efforts with the Commercial organization. The aim is to develop and execute a global commercialization strategy for each product, while sharpening execution at the country level. In order to better serve payers, physicians and patients, we will rely on new cooperative models among our marketing, medical and access teams. Lamberto Andreotti, Chief Executive Officer, BMS
- 229. 228 A Collaborative development of new analytics assets and capabilities B Integrated, standardized analytics delivery to country, cluster and WW teams C Centralized analytics hub providing WW analytics support Develop new analytics capability Pilot in selected countries Re-calibrate based on learnings Leverage capability across countries
- 230. 229 Forecasting Performance Management and Reporting Customer Analytics Integrated, standardized analytics delivery to country, cluster and WW teams A B C
- 231. 230 Sponsoring Board Global Program Board IT, Business, Project & Services Delivery
- 232. 231 Message Overview • Add content summary • Then definitions/overview for each section following table of contents
- 234. 233 Pre-cursors Module Scope Comprehensive Market & Product Assessment Product Forecast Sizing Structuring Disease overview Product analysis Diagnosis Treatment Regulatory Segmentation Targeting Unmet need Pipeline CI Key insights Patient based Analog analysis Top-line Historical data Conversion parameters Assessment of inputs from MA, “As Is” and forecasting Promotional responsiveness Effort estimation Yield determination Portfolio optimization Selling process Synergies across therapy areas Segmentation on physician potential, specialty, activities Scenario analysis
- 235. 234 Unique ability to understand healthcare specific Client needs GAP IT Geographic Reach
- 236. 235 Innovative Analytics• Healthcare Analytics Innovations Lab • Focus on Embedded Prescriptive Analytics in Workflow • Analytics on Local Market Dynamics • Beijing Analytics Hub + Global Delivery Model • Support all Types of Analytics • Compliance Privacy, Usage, De-identification Capabilities and Understanding • Access to Information +, Big Data +, RWE ++
- 237. 236 Look and Feel • Define visual positing and attitude Communication Strategy • Channel Strategy (when, what, where) • Refine Offerings Messaging • Thought Leadership • Work With Global Teams for Stronger Coordination (Best Practices) August September November October Communication Framework • Overarching Service Story • Managed Services positioning and offerings Sales Deck • Training deck for sales teams & client facing deck to enable stronger client presentations Client Conference Tool Kit Centralized Sales Resources Center • Sales enablement tools complete and live online Updated Web
- 238. 237 Aligned Org Simple Cross Functional Mobile Insights to Actions Predictive Scalable Agile Fast
- 239. 238 Shift in stakeholder mix focusing on new groups such as payer Flexible organisation structure to respond to environmental changes New channels and technologies are leveraged, e.g. digital offerings and RWE More effective commercial approaches
- 241. 240 99.95% availability Always up Always on SSO integrated with on- premise Active Directory/LDAP/O Auth Security Scale up as demand increases Elasticity Geo-located redundancy bringing the data closer to the customer and compliant with local regulations Speed of Access Geo-located redundancy bringing the data closer to the customer and compliant with local regulations Americas Asia-PacificEurope
- 242. 241 4 3 2 1 5 Level 5 is the complete User Manual e.g. This document will detail all aspects related to the process from Overview to procedural steps. All escalation points and corresponding team details will be mentioned. Will include screenshots for all communications and tools Level 4 are Prompts for recording information e.g. Data availability status on Tracker 1. Missing information on Tracker 2. Queries on Tracker 3. Client monthly analysis status on Tracker 4 Level 3 defines How the task will be done e.g. The data is received in generic Mailbox in the form of .txt and .xls. This data is loaded on the in-built tools and analyzed daily. All queries are routed to stakeholders. Status for each client is updated on tracking and query sheets Level 2 defines Who will do What and When e.g. Sales Data from providers is collected by Production Team for 9 working days. This data is then processed by them and analyzed for 3 days. Dispatch occurs on Day 13. CD dispatch is facilitated by stakeholders in Switzerland Level 1 defines Approach e.g. The Switzerland Production team works on a creating standard databases from Sales Data. This data is received on a monthly basis and delivered as per set timelines
- 243. 242 • The Q3 report has been delivered • Awaiting data for Q4 2014
- 244. 243 Saudi Health Council • Lead • Coordinate • Facilitate IMS • Execute • Liaise Industry • Sponsor • Facilitate
- 245. 244 Implementation of studyDesign evaluation studyReview program 1 2 3
- 246. 245 1 Drive Lean Sigma culture with a focused group coordinators 2 Accomplish 100% Lean Sigma training by Q4 2014 3 Implement ‘Just Do It’ and Kaizen projects in all teams by Q1 2015 4 Establish a certification process for Lean trained resources by Q1 2015 Contacts Urmi Chakraborty UChakraborty@in.imshealth.com Sandeep Rao Sandeep.Rao@in.imshealth.com
- 247. 246 Challenges • Processes inherited from transitions • People dependency • Absence of metrics and compliance • Rework • Schedule slippage • Unhappy stakeholders Mitigation • Standardized processes • Responsibility matrix • Metrics • Compliance audit • On time delivery with quality • People independent • Happy stakeholders
- 248. 247 Goal To achieve Compliance
- 249. 248
- 250. 249
- 251. 250
- 252. 251
- 253. 252IMS Health Confidential ……Through its teams of experts across globe Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Domain Inputs In-depth clinical insights based on inputs from medical professionals with long standing clinical and commercial experience Primary Survey Capability to undertake primary studies utilizing in-house benchmark primary studies methodologies across the globe R&DProductDevelopment Option 1
- 254. 253IMS Health Confidential ……Through its teams of experts across globe Commercial Inputs Commercial relevant analytical inputs based on extensive consulting experience Primary Survey Capability to undertake primary studies utilizing in-house benchmark primary studies methodologies across the globe Domain Inputs In-depth clinical insights based on inputs from medical professionals with long standing clinical and commercial experience Data Analytics Analysis based on in- house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Option 1
- 255. 254IMS Health Confidential ……Through its teams of experts across globe Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Option 1
- 256. 255IMS Health Confidential ……Through its teams of experts across globe Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Domain Inputs In-depth clinical insights based on inputs from medical professionals with long standing clinical and commercial experience Primary Survey Capability to undertake primary studies utilizing in-house benchmark primary studies methodologies across the globe R&DProductDevelopment Option 2
- 257. 256IMS Health Confidential ……Through its teams of experts across globe Commercial Inputs Commercial relevant analytical inputs based on extensive consulting experience Primary Survey Capability to undertake primary studies utilizing in-house benchmark primary studies methodologies across the globe Domain Inputs In-depth clinical insights based on inputs from medical professionals with long standing clinical and commercial experience Data Analytics Analysis based on in- house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Option 2
- 258. 257IMS Health Confidential ……Through its teams of experts across globe Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Data Analytics Analysis based on in-house databases such as R&D focus, Disease Insights, Market prognosis, Analytics Link Option 2